Table 3.
Association between HRR capacity and breast cancer risk in case–control study
| Controls, N (%) | Cases, N (%) | Unadj. OR (95% CI) | P value | Adj. OR (95% CI)a | P value | |
|---|---|---|---|---|---|---|
| HRR capacity | ||||||
| Continuous (0.1% unit) | 152 (100) | 152 (100) | 1.58 (1.32, 2.84) | <0.001 | 1.42 (1.21–2.53) | <0.001 |
| By 75% in controls | ||||||
| ≥12.71% | 113 (74.34) | 83 (34.85) | Reference | Reference | ||
| <12.71% | 39 (25.66) | 69 (65.15) | 2.41 (1.44, 4.03) | <0.001 | 1.97 (1.18–3.34) | 0.001 |
| By tertile in the controls | ||||||
| High | 50 (32.89) | 32 (21.05) | Reference | Reference | ||
| Medium | 51 (33.55) | 51 (33.55) | 1.56 (0.83, 2.94) | 0.137 | 1.50 (0.79–3.08) | 0.148 |
| Low | 51 (33.55) | 69 (45.39) | 2.11 (1.15, 3.91) | 0.01 | 1.89 (1.07–4.23) | 0.012 |
| P for trend | <0.001 | <0.001 |
aAdjusted by age, race, BMI category, smoking status, alcohol status and physical activity.